Screening of male patients for Trichomonas vaginalis with transcription-mediated amplification in a community with a high prevalence of sexually transmitted infection

Journal of Clinical Microbiology

Volumn 51, Issue 1, 2013, Pages 101-104

  Munson, Kimber L ^a   Napierala, Maureen ^a   Munson, Erik ^a,b   Schell, Ronald F ^c,d   Kramme, Timothy ^a   Miller, Cheryl ^a   Hryciuk, Jeanne E ^a  

^a Wheaton Franciscan Laboratory   (United States)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^c WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; CAUCASIAN; CHLAMYDIA TRACHOMATIS; COMMUNITY ASSESSMENT; ETHNIC DIFFERENCE; FOLLOW UP; GENE AMPLIFICATION; HEALTH CARE SYSTEM; HUMAN; MALE; MICROORGANISM DETECTION; MOLECULAR DIAGNOSIS; NEISSERIA GONORRHOEAE; PARASITE EXAMINATION; PARASITE PREVALENCE; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION MEDIATED AMPLIFICATION; TREND STUDY; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; URETHRAL SWAB; URINALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PARASITOLOGY; PREVALENCE; RETROSPECTIVE STUDIES; SEXUALLY TRANSMITTED DISEASES; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS; URETHRA; URINE; YOUNG ADULT;

CHLAMYDIA TRACHOMATIS; HUMAN IMMUNODEFICIENCY VIRUS; NEISSERIA GONORRHOEAE; TRICHOMONAS VAGINALIS;

EID: 84871694420     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02526-12     Document Type: Article

References (30)

1. Weinstock H, Berman S, Cates W, Jr. 2004. Sexually transmitted diseases among American youth: incidence and prevalence estimates. Perspect. Sex. Reprod. Health 36:6-10. (Pubitemid 38258322)
2. Chesson HW, Blandford JM, Pinkerton SD. 2004. Estimates of the annual number and cost of new HIV infections among women attributable to trichomoniasis in the United States. Sex. Transm. Dis. 31:547-551. (Pubitemid 39122137)
3. Guenthner PC, Secor WE, Dezzutti CS. 2005. Trichomonas vaginalis-induced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: implications for the sexual transmission of HIV-1. Infect. Immun. 73:4155-4160. (Pubitemid 40923157)
4. Hobbs MM, Kazembe P, Reed AW, Miller WC, Nkata E, Zimba D, Daly CC, Chakraborty H, Cohen MS, Hoffman I. 1999. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex. Transm. Dis. 26:381-387. (Pubitemid 29372769)
5. Kissinger P, Amedee A, Clark RA, Dumestre J, Theall KP, Myers L, Hagensee ME, Farley TA, Martin DH. 2009. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex. Transm. Dis. 36:11-16.
6. Heine P, McGregor JA. 1993. Trichomonas vaginalis: a reemerging pathogen. Clin. Obstet. Gynecol. 36:137-144. (Pubitemid 23065139)
7. Huppert JS, Hesse E, Kim G, Kim M, Agreda P, Quinn N, Gaydos C. 2010. Adolescent women can perform a point-of-care test for trichomoniasis as accurately as clinicians. Sex. Transm. Infect. 86:514-519.
8. Munson E, Napierala M, Olson R, Endes T, Block T, Hryciuk JE, Schell RF. 2008. Impact of Trichomonas vaginalis transcription-mediated amplification-based analyte-specific-reagent testing in a metropolitan setting of high sexually transmitted disease prevalence. J. Clin. Microbiol. 46:3368-3374.
9. Nye MB, Schwebke JR, Body BA. 2009. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am. J. Obstet. Gynecol. 200: 188.e1-7.
10. Napierala M, Munson E, Munson KL, Kramme T, Miller C, Burtch J, Olson R, Hryciuk JE. 2011. Three-year history of transcription-mediated amplification-based Trichomonas vaginalis analyte-specific reagent testing in a subacute care patient population. J. Clin. Microbiol. 49:4190-4194.
11. Schwebke JR, Lawing LF. 2002. Improved detection by DNA amplification of Trichomonas vaginalis in males. J. Clin. Microbiol. 40:3681-3683.
12. Wendel KA, Erbelding EJ, Gaydos CA, Rompalo AM. 2003. Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD clinic. Sex. Transm. Infect. 79:151-153. (Pubitemid 36469623)
13. Miller WC, Swygard H, Hobbs MM, Ford CA, Handcock MS, Morris M, Schmitz JL, Cohen MS, Harris KM, Udry JR. 2005. The prevalence of trichomoniasis in young adults in the United States. Sex. Transm. Dis. 32:593-598. (Pubitemid 41429179)
14. Huppert JS, Mortensen JE, Reed JL, Kahn JA, Rich KD, Miller WC, Hobbs MM. 2007. Rapid antigen testing compares favorably with transcription- mediated amplification assay for the detection of T. vaginalis in young women. Clin. Infect. Dis. 45:194-198. (Pubitemid 47041010)
15. Centers for Disease Control and Prevention. 2011. Sexually transmitted disease surveillance, 2010. US Department of Health and Human Services, Atlanta, GA.
16. Hardick A, Hardick J, Wood BJ, Gaydos C. 2006. Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a Roche LightCycler instrument with female self-obtained vaginal swab samples and male urine samples. J. Clin. Microbiol. 44:4197- 4199.
17. Gaydos CA, Quinn TC, Willis D, Weissfeld A, Hook EW, Martin DH, Ferrero DV, Schachter J. 2003. Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J. Clin. Microbiol. 41: 304-309. (Pubitemid 36098592)
18. Munson E, Miller C, Napierala M, Kramme T, Olson R, Munson KL, Olson S, Hryciuk JE, Schell RF. 2012. Assessment of screening practices in a subacute clinical setting following introduction of Trichomonas vaginalis nucleic acid amplification testing. Wisc. Med. J. 111:233-236.
19. Andrea SB, Chapin KC. 2011. Comparison of Aptima Trichomonas vaginalis transcription-mediated amplification assay and BD Affirm VPIII for detection of T. vaginalis in symptomatic women: performance parameters and epidemiological implications. J. Clin. Microbiol. 49:866-869.
20. Munson E, Kramme T, Napierala M, Munson KL, Miller C, Hryciuk JE. 2012. Female epidemiology of transcription-mediated amplification-based Trichomonas vaginalis detection in a metropolitan setting with a high prevalence of sexually transmitted infection. J. Clin. Microbiol. 50: 3927-3931.
21. Munson E, Firmani MA. 2009. Molecular diagnosis of Neisseria gonorrhoeae infection in the United States. Expert Opin. Med. Diagn. 3:327-343.
22. Munson E, Napierala M, Basile J, Miller C, Burtch J, Hryciuk JE, Schell RF. 2010. Trichomonas vaginalis transcription-mediated amplification-based analyte-specific reagent and alternative target testing of primary clinical vaginal saline suspensions. Diagn. Microbiol. Infect. Dis. 68 : 66-72.
23. Krashin JW, Koumans EH, Bradshaw-Sydnor AC, Braxton JR, Evan Secor W, Sawyer MK, Markowitz LE. 2010. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population. Sex. Transm. Dis. 37:440-444.
24. Stark JR, Judson G, Alderete JF, Mundodi V, Kucknoor AS, Giovannucci EL, Platz EA, Sutcliffe S, Fall K, Kurth T, Ma J, Stampfer MJ, Mucci LA. 2009. Prospective study of T. vaginalis infection and prostate cancer incidence and mortality: physicians' health study. J. Natl. Cancer Inst. 101:1406 -1411.
25. Sutcliffe S, Giovannucci E, Alderete JF, Chang TH, Gaydos CA, Zenilman JM, De Marzo AM, Willett WC, Platz EA. 2006. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 15:939-945. (Pubitemid 43823521)
26. Sutcliffe S, Alderete JF, Till C, Goodman PJ, Hsing AW, Zenilman JM, De Marzo AM, Platz EA. 2009. Trichomonosis and subsequent risk of prostate cancer in the prostate cancer prevention trial. Int. J. Cancer 124: 2082-2087.
27. Schwebke JR, Hobbs MM, Taylor SN, Sena AC, Catania MG, Weinbaum BS, Johnson AD, Getman DK, Gaydos CA. 2011. Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial. J. Clin. Microbiol. 49:4106-4111.
28. Chernesky M, Jang D, Luinstra K, Chong S, Smieja M, Cai W, Hayhoe B, Portillo E, MacRitchie C, Main C, Ewert R. 2006. High analytical sensitivity and low rates of inhibition may contribute to detection of Chlamydia trachomatis in significantly more women by the APTIMA Combo 2 assay. J. Clin. Microbiol. 44:400-405.
29. Ikeda-Dantsuji Y, Konomi I, Nagayama A. 2005. In vitro assessment of the APTIMA Combo 2 assay for the detection of Chlamydia trachomatis using highly purified elementary bodies. J. Med. Microbiol. 54:357-360. (Pubitemid 40489541)
30. Schachter J, Chow JM, Howard H, Bolan G, Moncada J. 2006. Detection of Chlamydia trachomatis by nucleic acid amplification testing: our evaluation suggests that CDC-recommended approaches for confirmatory testing are ill-advised. J. Clin. Microbiol. 44:2512-2517. (Pubitemid 44092420)